Fangzhou Inc. unveiled its new AI system, “XingShi” Large Language Model, designed to enhance chronic disease management by improving efficiency, personalization, and optimizing physicians’ time. The model integrates image and speech recognition, natural language processing, and medical knowledge storage, supporting five intelligent agents for comprehensive care. This launch marks a significant advancement in Fangzhou’s AI capabilities, aligning with China’s “AI+” policy to drive innovation in healthcare. The company aims to leverage XS LLM for future R&D in chronic disease management applications, reinforcing its commitment to scalable and precise healthcare delivery.

Read more at GlobeNewswire: Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic